HLTH:AU:AU-VanEck Global Healthcare Leaders ETF (AUD)

ETF | Others |

Last Closing

USD 11.57

Change

+0.11 (+0.96)%

Market Cap

USD 0.06B

Volume

4.31K

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

NA

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-05-21 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
VAS:AU Vanguard Australian Shares

+0.50 (+0.48%)

USD 18.39B
IVV:AU iShares Core S&P 500 AUD

-0.46 (-0.75%)

USD 11.33B
VGS:AU Vanguard MSCI International Sh..

-0.68 (-0.49%)

USD 10.39B
QUAL:AU VanEck Vectors MSCI World ex A..

-0.40 (-0.69%)

USD 7.35B
IOZ:AU Ishares Core S&P/Asx 200

+0.18 (+0.53%)

USD 6.40B
VTS:AU Vanguard US Total Market Share..

-3.68 (-0.81%)

USD 5.71B
STW:AU SPDR® S&P/ASX 200 Fund

+0.26 (+0.34%)

USD 5.54B
NDQ:AU Betashares Nasdaq 100

-0.39 (-0.79%)

USD 5.22B
HNDQ:AU BetaShares NASDAQ 100 ETF - Cu..

-0.19 (-0.44%)

USD 4.86B
A200:AU BetaShares Australia 200

+0.72 (+0.51%)

USD 4.72B

ETFs Containing HLTH:AU

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 2.75% 67% D+ 63% D
Dividend Return N/A N/A N/A N/A N/A
Total Return 2.75% 62% D 60% D-
Trailing 12 Months  
Capital Gain 5.76% 54% F 64% D
Dividend Return 0.82% 9% A- 6% D-
Total Return 6.58% 39% F 60% D-
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain 1.09% 33% F 47% F
Dividend Return 1.51% 24% F 42% F
Total Return 0.41% 7% C- 7% C-
Risk Return Profile  
Volatility (Standard Deviation) 8.96% 59% D- 90% A-
Risk Adjusted Return 16.83% 20% F 49% F
Market Capitalization 0.06B 14% F 50% F

Annual Financials (AUD)

Quarterly Financials (AUD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:
Poor risk adjusted returns

This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.

Below median dividend returns

The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.

Below median total returns

The company has under performed its peers on annual average total returns in the past 5 years.

Low market capitalization

This is among the smaller entities in its sectors with below median market capitalization. That may make it less stable in the long run unless it has a unique technology or market which can help it grow or get acquired in future.